Neurocrine Biosciences (NBIX) had the highest return in January 2014 by a large-cap US stock, returning 84.4%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Neurocrine Biosciences (NBIX) | January 2014 | 84.36% |
TKO (TKO) | January 2014 | 46.16% |
Arrowhead Pharmaceuticals (ARWR) | January 2014 | 42.7% |
Illumina (ILMN) | January 2014 | 37.58% |
Everpure (P) | January 2014 | 36.32% |
Alnylam Pharmaceuticals (ALNY) | January 2014 | 30.21% |
Incyte (INCY) | January 2014 | 30.21% |
United Airlines (UAL) | January 2014 | 21.59% |
Tesla (TSLA) | January 2014 | 21.1% |
Insmed (INSM) | January 2014 | 20.69% |
Super Micro Computer (SMCI) | January 2014 | 20.66% |
AngloGold Ashanti (AU) | January 2014 | 20.59% |
Advanced Energy Industries (AEIS) | January 2014 | 20.11% |
Cytokinetics (CYTK) | January 2014 | 19.78% |
Jazz Pharmaceuticals (JAZZ) | January 2014 | 19.65% |
Royal Gold (RGLD) | January 2014 | 18.77% |
F5 Networks (FFIV) | January 2014 | 18.36% |
IES (IESC) | January 2014 | 18.22% |
Franco-Nevada (FNV) | January 2014 | 17.76% |
Knight Transportation (KNX) | January 2014 | 16.99% |
Logitech International (LOGI) | January 2014 | 16.65% |
Acuity Brands (AYI) | January 2014 | 16.43% |
Insulet (PODD) | January 2014 | 16.22% |
Globus Medical (GMED) | January 2014 | 16.13% |
NVR (NVR) | January 2014 | 15.92% |
Large-cap stocks are treated as having a market cap of $10B+.